Figure 2 | Scientific Reports

Figure 2

From: Preclinical evaluation of ribociclib and its synergistic effect in combination with alpelisib in non-keratinizing nasopharyngeal carcinoma

Figure 2

In vitro effects of ribociclib on cell cycle arrest. Representative graphs showing cell cycle distribution on C666-1 and HK1 cells treated with DMSO control and three different concentrations of ribociclib, one of them near their corresponding IC50, for 16, 24 and 48 hours. Cell cycle data are summarized from three independent trials and presented as mean ± SEM.

Back to article page